Safety of off-label stroke treatment with tissue plasminogen activator-Reference-Cited by-同舟云学术

Safety of off-label stroke treatment with tissue plasminogen activator

Published:2013-01-11 Issue:1 Volume:128 Page:48-53
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Kvistad C. E.¹,Logallo N.¹,Thomassen L.,Waje-Andreassen U.¹,Brøgger J.¹,Naess H.¹

Affiliation:

1. Centre for Neurovascular Diseases; Department of Neurology; Haukeland University Hospital; Bergen; Norway

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12076/fullpdf

Reference27 articles.

1. Helsedirektoratet: Nasjonal retningslinje for behandling og rehabilitering ved hjerneslag 2010 http://www.helsebiblioteket.no/retningslinjer/hjerneslag/vedlegg/kriterier-trombolytisk

2. Are all iv thrombolysis exclusion criteria necessary? Being smart about evidence-based medicine;Tong;Neurology,2011

3. Iv tissue plasminogen activator use in acute stroke: experience from a statewide registry;Deng;Neurology,2006

4. Why are stroke patients excluded from tpa therapy? An analysis of patient eligibility;Barber;Neurology,2001

5. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients;Berrouschot;Stroke,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombocytopenia and In-hospital outcomes in patients with acute ischemic stroke undergoing intravenous thrombolysis: Findings from a nationwide registry study in China;Journal of Stroke and Cerebrovascular Diseases;2024-08

2. Is off-label thrombolysis safe and effective in a real-life primary stroke center? A retrospective analysis of data from a 5-year prospective database;Revue Neurologique;2022-12

3. Intravenous thrombolysis in ischemic stroke patients with a prior intracranial hemorrhage: a meta-analysis;Therapeutic Advances in Neurological Disorders;2022-01

4. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke;European Stroke Journal;2021-02-19

5. The Clinical Conundrum of Managing Ischemic Stroke in Patients with Immune Thrombocytopenia;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2020-07-10